Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

The Mpox (formerly known as monkeypox) outbreak in the US hit its peak in August of 2022, and has declined from causes about 400 illnesses a day to just one, but that doesn’t mean the danger is completely gone, the Centers for Disease Control and Prevention explained in a teleconference on May 18, 2023. In May 2023, the World Health Organization (WHO) declared an end to the global health emergency. While cases are fewer, breakouts are still happening. Between mid April 2023 and early May, experts identified an outbreak of 21 men with Mpox in the Chicago area. “All have…

Read More

You’ve heard the words macular degeneration, but what do you know about the disease and its recommended treatments? What can you do to lessen its effects? Read on to find out more. Only one treatment exists for what’s called wet age-related macular degeneration (AMD), a progressive disease that causes blindness emanating from the center of the eye. To treat it, your doctor gives you direct injections of anti-vascular endothelial growth factor (VEGF) into the affected eye. For the more common dry AMD, there aren’t any approved treatments. But there are two well-known ways to reduce your risk of getting AMD:…

Read More